2024 HPTN Annual Meeting: Recordings and Presentations

Recordings and Presentations

CWG Plenary I

State of the Network: The Way Forward for the HPTN – Wafaa M. El-Sadr 

Tackling the HIV/STI Syndemic – Myron S. Cohen 

Broadly Neutralizing Antibodies (bnAbs): Where We’ve Been and Where We’re Going – Gail Broder 

 

CWG Plenary II

Lessons Learned: CAB-LA Rollout – Kristine Torjesen 

Trauma-Informed HIV Prevention Strategies for Transgender, Nonbinary, and Gender Diverse People – Sari Reisner 

Creating a Social Media Campaign for Black MSM in the Southern United States – Rameses Frederick and Kameron Jacobs 

Long-acting PrEP for People Who Inject Drugs: HPTN 103 and Beyond – Sunil Solomon

 

CWG Plenary II

HIV Among Sexual and Gender Minorities in Latin America – Mayara Secco 

HPTN Black Caucus – Craig Hutchinson 

Combination Strategies for HIV Prevention and Contraception – Kate Segal and Nandisile (Luthuli) Sikwana
 

HPTN and ACTG Joint Plenary

LATITUDE: Comparing a Monthly Injectable ART to Daily Oral Drugs – Timothy Wilkin 

Integrase Resistance: How to Manage in Less than Perfectly Monitored Populations – Monica Gandhi 

INSTI Resistance in the Setting of CAB-LA PrEP – Susan Eshleman 

Reaching Populations with High HIV Incidence and Limited Access to Services – Ernest Moseki and Mardrequs Harris 

 

HPTN Scholars Plenary

Recording

The Association Between Support Interventions and Adherence to HIV Pre-Exposure Prophylaxis Among Young African Women (HPTN 082) – Abubaker Saeed 

Stigma and Sexually Transmitted Infections Among Black Men Who Have Sex with Men (HPTN 061) – Melonie Walcott 

Correlates of Long-Acting Reversible Contraceptive Use Among Young Women in Southern Africa (HPTN 082) – Phionah Kibalama Ssemambo 

Substance Use and Self-Related Health Among Women at Risk of HIV Acquisition (HPTN 064) – Olatokunbo Osibogun 

HPTN Plenary I

Recording

Division of Microbiology and Infectious Diseases (DMID) Priorities – Emily Erbelding 

U.S. Centers for Disease Control and Prevention (CDC) HIV Prevention Priorities – Robyn Neblett Fanfair 

 

Building the Prevention Toolbox

Recording

Broadly Neutralizing Antibodies (bnAbs) at the Crossroads: What Lies Ahead? – Dan Barouch 

New Long-Acting Agents for HIV Prevention – Charles Flexner 

Design of PrEP Preference Trials – Elizabeth Brown 

Circumcision – Possible Option for Some MSM? – Sten Vermund 

 

Using the Prevention Toolbox

Recording

Reaching Men: HPTN 111 (TRIM) – Zubair Lukyazumi 

Incorporating AI-Enabled Ultrasound into HIV Prevention Research – Jeffrey Stringer 

Use of Modeling for Identification of Priority Populations for HIV Epidemic Response – Romain Silhol 

On Demand PrEP Dosing (2-1-1) for Women – Mackenzie Cottrell

 

Pharmaceutical Affairs Branch (PAB) Session

Site Inspection Preparedness

Updates: DAIDS Pharmacy Guidelines – Kelly Colsh

HPTN Plenary II

Recording

National Institute of Allergy and Infectious Diseases (NIAID) Prevention Priorities – Jeanne Marrazzo 

Division of AIDS (DAIDS) Update and Network Re-Competition – Carl Dieffenbach 

 

Laboratory Center Plenary and Network Awards

Recording

Targeted LC-HRMS with Library Matching for Toxicology Screening – Bill Clarke 

Assessing Antimicrobial Resistance in STIs in HIV Prevention Trials – Johan Melendez 

Update on HIV Diagnostic Testing in the Setting of CAB-LA PrEP – Susan Eshleman